Management of Chronic Kidney Disease in the Elderly

Understanding Renal Function Assessment

Serum creatinine alone is an inadequate measure of renal function in elderly patients because creatinine production decreases with age-related muscle mass loss, and a "normal" creatinine can mask significant renal impairment, with one in five patients having asymptomatic renal insufficiency when properly assessed 1, 2, 3
The reported eGFR of 89 mL/min/1.73m² classifies a patient as Stage 2 CKD (mild decrease in GFR, range 60-89 mL/min/1.73m²) according to the National Kidney Foundation classification, but creatinine-based eGFR equations can overestimate true renal function in elderly patients with low muscle mass 1, 2, 3, 4

All guideline-based interventions for chronic kidney disease begin at eGFR <60 mL/min/1.73m² (Stage 3 or higher), and specific management protocols include monitoring hemoglobin, blood pressure, nutritional status, and dyslipidemia, as well as discussion of renal replacement therapy modalities, starting at eGFR <30 mL/min/1.73m² 5, 6
Annual screening is appropriate for patients with Stage 2 CKD, consisting of urine routine examination, urinary albumin/creatinine ratio (UACR), and serum creatinine for eGFR calculation 7, 8
The American Society of Nephrology recommends monitoring hemoglobin every 3 months, starting at eGFR <30 mL/min/1.73m² 6
The American Society of Nephrology recommends blood pressure monitoring at every clinic visit, starting at eGFR <30 mL/min/1.73m² 5, 6

The MDRD formula provides better accuracy than the Cockcroft-Gault formula for estimating GFR in elderly patients, as Cockcroft-Gault tends to underestimate GFR more significantly in older adults 9
Cystatin C-based eGFR estimation is superior to creatinine-based methods in elderly patients with low muscle mass, although this information is not directly cited, the importance of accurate eGFR calculation is emphasized 1, 2, 3